Publications by authors named "Sandy Simon"

Claim this Profile
O
Olaparib, durvalumab, and cyclophosphamide, and a prognostic blood signature in platinum-sensitive ovarian cancer: the randomized phase 2 SOLACE2 trial.
Chee Khoon Lee, Apriliana E R Kartikasari, Nirashaa T Bound, Katherine E Francis, Kristy Shield-Artin, Sandy Simon

Nat Commun· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Under the radar-frequency, timing, duration, and trajectory of lower-grade adverse events in clinical trials of anti-cancer therapies.
Katherine E Francis, Sarah J Lord, Sandy Simon, Michael Friedlander, Val Gebski

Oncologist· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse events in the placebo arm of SOLO2/ENGOT-Ov21 maintenance trial of olaparib in recurrent ovarian cancer.
Katherine Elizabeth Francis, Sandy Simon, Val Gebski, Florence Joly, Jonathan A Ledermann

Gynecol Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Choice of fusion proteins, expression host, and analytics solves difficult-to-produce protein challenges in discovery research.
Sally Lyons-Abbott, Ariel Abramov, Chung-Leung Chan, Jen Running Deer, Guangsen Fu, Sandy Alexander Simon

Biotechnol J· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Verbal Card Sorting Task to Measure Executive Functions.
Arianna N LaCroix, Alexandria Greene-Winek, Sandy Simon, Hannah Groth, Ileana Ratiu

Am J Speech Lang Pathol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse events in the placebo arm of maintenance therapy trials in advanced ovarian cancer: A systematic review and meta-analysis.
Sandy Simon, Katherine E Francis, Janene E Dalrymple, Val Gebski, Sarah J Lord

Eur J Cancer· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG.
Anahid Ehteda, Sandy Simon, Laura Franshaw, Federico M Giorgi, Jie Liu

Cell Rep· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electroconvulsive therapy in a patient with hypertrophic obstructive cardiomyopathy.
Emma Bowes, Anne Pf Wand, Sandy Simon

Aust N Z J Psychiatry· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis